Semaglutide is a GLP-1 receptor agonist researched for its effects on appetite signalling, glucose metabolism, and weight management pathways. It remains one of the most widely studied peptides within metabolic and obesity-related research.
FOR RESEARCH PURPOSES ONLY, NOT FOR HUMAN CONSUMPTION
Semaglutide is a GLP-1 receptor agonist researched for its effects on appetite signalling, glucose metabolism, and weight management pathways. It remains one of the most widely studied peptides within metabolic and obesity-related research.
FOR RESEARCH PURPOSES ONLY, NOT FOR HUMAN CONSUMPTION